- Home
- MRSN vs WEA Comparison
MRSN vs WEA Comparison
Compare MRSN & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRSN | WEA |
|---|---|---|
| Founded | 2001 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 130.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRSN | WEA |
|---|---|---|
| Price | $29.08 | $11.06 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $30.38 | N/A |
| AVG Volume (30 Days) | ★ 52.9K | 46.1K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,180,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $9.60 |
| 52 Week High | $40.88 | $11.29 |
Technical Indicators
Market Signals| Indicator | MRSN | WEA |
|---|---|---|
| Relative Strength Index (RSI) | 82.82 | 49.31 |
| Support Level | $28.85 | $10.93 |
| Resistance Level | $29.39 | $11.06 |
| Average True Range (ATR) | 0.46 | 0.09 |
| MACD | -0.53 | 0.01 |
| Stochastic Oscillator | 77.67 | 50.00 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.